Tucson, AZ (PRWEB) June 20, 2014
Dr. Evan Unger, President and CEO of NuvOx Pharma, will present at the 2014 Annual International BIO Meeting in the Platform Technologies session at the San Diego Convention Center on Tuesday, June 24th at 11:15 am in the Mission Bay Room.
NuvOx nanotechnology platform delivers oxygen from simple IV injection to treat life-threatening conditions with impaired oxygen delivery. NVX-108 is currently in a Phase Ib/II clinical trial to treat brain tumors with irradiation. Brain tumors are commonly hypoxic (low oxygen) adversely affecting response to radiotherapy. NVX-108 increases oxygen in the tumor tissue to improve radiation response.
In addition, NuvOx is developing products for other indications based upon its nanotechnology platform. Completed animal studies show decreased damage to the brain and heart from stroke and heart attack by 85% as well as effective treatment of hemorrhagic shock and traumatic brain injury.